Meanwhile, in the exploratory in vitro data, LPS further restored the downstream targets of TLR4/MyD88, including Sp1, STAT3, p38 MAPK and NF‐κB p65, in geniposide‐treated HCC cells (Figure 5e). The gene discussed is STAT3; the disease is hepatocellular carcinoma.